Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYR-472 Open-label Study in Diabetic Patients
NCT01751360Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Apr 2013; status: completed.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01751360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751360.